Skip to main content
. Author manuscript; available in PMC: 2021 Aug 23.
Published in final edited form as: Breast Cancer Res Treat. 2020 Apr 11;181(2):423–434. doi: 10.1007/s10549-020-05611-8

Table 1.

Predictors included in current contralateral breast cancer risk prediction tools

List of predictors CBCriskb Manchester formulac PredictCBC version 1Ad PredictCBC version 1Bd
Age at diagnosis
Age at first birth
First-degree family history
BRCA1/2 germline mutation
First breast cancer behavior typea
Lymph node status
Breast density
Tumor size
Morphology
Tumor grade
High-risk pre-neoplasia
ER status
HER2 status
Chemotherapy
Endocrine therapy
Radiation to the breast
Trastuzumab
Oophorectomy under 40 years

ER estrogen-receptor status, HER2 human epidermal growth factor receptor 2

a

Contralateral breast cancer risk was calculated including women diagnosed with ductal carcinoma in situ

b

Chowdhury et al. [7]

c

Basu et al. [8]

d

Giardiello et al. [5]